Team:Cambridge/Project/CA02
From 2009.igem.org
BACKGROUND
Carotenoids are organic pigments naturally present in plants, algae and
some bacteria. There are more than 600 carotenoids, which can be categorized
into xanthophylls (hydrocarbons containing oxygen) and carotenes (hydrocarbons
containing no oxygen). Carotenoids perform a range of functions, including
light energy absorption, protection against photo-damage, acting as
antioxidants, and as precursor to other organic compounds. In human, for
example, beta-carotene is the precursor to vitamin A.
Biochemical pathway of carotenoid synthesis
The common starting
point for carotenoid synthesis is farnesyl pyrophosphate (FPP), which
derives from two precursors, isopentenyl pyrophosphate (IPP) and dimethylallyl
pyrophosphate (DMAPP). In general, there are two pathways for synthesising IPP
and DMAPP: the Mevalonate Pathway (starting with acetyl CoA) and the
Non-mevalonate Pathway (starting with pyruvate and glyceradehyde-3-phosphate).
While the Mevalonate Pathway is present in all higher eukaryotes, the Non-mevalonate Pathway is
present in E. coli.
Mevalonate Pathway (image adopted from Wikipedia, http://en.wikipedia.org/wiki/Mevalonate_pathway) |
Non-mevalonate Pathway (image adopted from Yuan et al.
2006) |
After IPP and DMAPP go
on to form FPP, a series of enzymatic reactions convert the colourless FPP to
coloured compounds: red lycopene, and orange β-carotene.
|
By modulating the enzymes
involved in this conversion pathway ("CrtE", "CrtB",
"CrtI", and "CrtY"), we aim to produce and control
different pigments as signal output.
DESIGN OF DEVICES
Biobricks contributed by previous iGEM teams
A few iGEM
teams of previous years (e.g.
Registry Code |
Team |
Sequence Description |
Size of insert |
K118014 |
|
922bp |
|
K118006 |
|
949bp |
|
K118005 |
|
1498bp 2 PstI sites removed. |
|
K118013 |
|
1162bp |
|
K152005 |
|
(rbs+CrtE) + (rbs+CrtB)
+ (rbs+CrtI) + (rbs+CrtY) + (rbs+GFP) |
5412bp 2 PstI sites in CrtI
removed. |
The above enzymes all come from a type of Gram negative
Enterobacteria, Pantoea ananatis (GenBank:
D90087.2). It is noted that analogues of these enzymes are also found in other
organisms (e.g. bacteria Rhodobacter
spp. and the fungus Neurospora crassa).
During our preliminary research, we have encountered a few
issues:
·
Originally, the registry annotation for K152005 indicated
that there was no ribosome binding site before gene CrtI (i.e.
“…rbs+CrtB+CrtI+rbs+CrtY…”). After clarification with Team Guelph 08, we were
told that it was an error in annotation. The registry entry for K152005 has
since been updated to include the ribosome binding site.
·
Teams of previous years constructed various composite parts
containing two or more enzymes of the synthetic pathways (e.g. CrtEBI,
CrtEBIY), but they are not available on the 2009 Distribution Plates.
·
We put K152005 under control of constitutive promoter
(R0011) and transformed the construct into E.coli TOP10 cells. However, the
plasmids seemed unstable (the colonies streaks on solid agar plates were
inconsistent in colour) and the pigment production was low. This indicated that
a different strain of E.coli might be needed for pigment production.
Create our own devices by standard assembly
Given the
information at hand, we decided to adopt the following general strategies:
- Create
a lycopene-producing device (with enzymes CrtE, CrtB and CrtI) by standard
assembly of Biobricks K118014, K118006 and K118005.
- Create
a β-carotene-producing device
(with enzymes CrtE, CrtB, CrtI and CrtY) by standard assembly of Biobricks
K118014, K118006, K118005 and K118013.
- Put the above two constructs under constitutive
promoter (R0011) and arabinose-induced promoter/Pbad (I0500) and test the
effect on colour production.
Scheme for standard assembly
|
Lycopene-producing
device |
β-carotene-producing
device |
Constituent
Biobricks (already in the registry) |
(K118014) (K118006) (K118005) |
(K118014) (K118006) (K118005) (K118013) |
Basic construct |
K274100 |
K274200 |
Under constitutive promoter |
K274110 |
K274210 |
Under Pbad promoter |
K274120 |
K274220 |
After constructing
our devices, we conducted restriction digest (cut with enzymes XbaI and PstI on
Biobrick prefix and suffix, respectively) to check that the sizes of the
inserts were correct. The results are as follows:
Biobrick Number |
Size of insert (kb) |
Size of backbone (kb) |
Note |
K274100 |
3.37 |
2.08 |
Digestion
result not shown. |
K274110 |
3.42 |
2.08 |
|
K274120 |
4.58 |
4.43 |
Sizes
of insert and backbone were similar so only one band appeared on gel. |
K274200 |
4.53 |
2.08 |
Digestion
result not shown. |
K274210 |
4.59 |
2.08 |
|
K274220 |
5.74 |
4.43 |
|
R0011-K152005* |
5.48 |
2.08 |
*These constructs were used in
preliminary research only. |
I0500-K152005* |
6.62 |
4.43 |
TESTING AND CHARACTERISATION
In vivo expression of
our devices in E.coli MG1655
Our preliminary research indicated that carotenoids
production in E.coli TOP10 was very weak. We decided to use another strain, E.coli MG1655, for in vivo expression of our devices. The amount of carotenoids
produced became visibly higher. Generally, the colour became visible after
incubation for about 12 hours.
Lycopene-producing device (constitutive)
|
|
E.coli MG1655 transformed with K274110
and grown on agar plate overnight. |
Cell pellet of E.coli MG1655
transformed with K274110 (from 20mL LB culture at |
β -carotene-producing device
(constitutive)
|
|
E.coli MG1655 transformed with K274210
and grown on agar plate overnight. |
Cell pellet of E.coli MG1655
transformed with K274210 (from 20mL LB culture at |
Quantitative measurement of pigment production
In
addition to visual inspection of coloured colonies, we hope to quantitatively
measure the amount of lycopene or β-carotene
produced by our devices. We grew transformed E.coli MG
Lycopene-producing device (constitutive)
Lycopene
in cells (pellet from 20mL LB culture at |
|
β -carotene-producing device
(constitutive)
β-carotene in cells (pellet from 20mL LB culture
at |
To investigate the
induction of pigment production, we tested our device K
β-carotene
in cells (pellet from 20mL LB culture at |
|
Discussion of results
Despite
relatively poor performance in E.coli
TOP10, our pigment-producing devices gave encouraging results in E.coli MG1655. Simply by overnight
incubation, the colonies were able to show visible colour changes. Since the
precursors were already present in normal E.coli,
no additional growth medium or special treatment was needed. This paves the way
to developing a signalling system that is quick to produce visual outputs.
The
acetone extraction of carotenoid provides a low-cost method for quantitative
measurement. In the above experiments, the results of photo-spectrometry were
consistent with characteristic absorbance wavelengths of lycopene (around
475nm) and β-carotene
(around 450nm), as noted in literature. In the case of β-carotene, the
absorbance profile of our β-carotene-producing device (K274210) matched
that of pure carotene standards, confirming that our device was functional in
the cells.
When we
overlay the graphs of our two devices (constitutive), we obtained the following
result:
|
red: K274110/lycopene; orange: K274210/β-carotene; black: pure β-carotene; blue: untransformed E.coli
MG1655 (negative control) |
Lycopene
and β-carotene showed characteristic absorbance profiles, with different
maximum absorbance wavelengths. It was tempted to think that by converting
lycopene to β-carotene (e.g. by expressing CrtY gene), we would be able to
see a “shift” in the peaks of maximum absorbance. However, in the bar charts
above it was noted that lycopene and β-carotene had significant absorbance
at both 456nm and 474nm, albeit with different ratios (i.e. lycopene absorbed
more at 474nm; β-carotene absorbed more at 456nm). Therefore, measurement
at a single wavelength was insufficient to determine the identity of the
carotenoid; we might need to use “456nm:474nm” ratio instead. It would be
interesting to see the effect of mixing different amounts of lycopene and β-carotene,
and whether the “456nm:474nm” ratio can indicate the relative percentage of
lycopene and β-carotene. In the current project, we were unable to obtain
pure lycopene due to high cost of purchase.
In terms
of inducing β-carotene production,
One
possible design using our devices is to construct a system where lycopene is
constitutively produced and CrtY, which converts red lycopene to orange β-carotene,
is controlled by external stimulus. Hence, the red cells will turn orange upon
sensing the specific external stimulus, and this change in colour serves as the
signal output that can be detected visually and measured quantitatively at low
cost.
BACKGROUND
Carotenoids are organic pigments naturally present in plants, algae and
some bacteria. There are more than 600 carotenoids, which can be categorized
into xanthophylls (hydrocarbons containing oxygen) and carotenes (hydrocarbons
containing no oxygen). Carotenoids perform a range of functions, including
light energy absorption, protection against photo-damage, acting as
antioxidants, and as precursor to other organic compounds. In human, for
example, beta-carotene is the precursor to vitamin A.
Biochemical pathway of carotenoid synthesis
The common starting
point for carotenoid synthesis is farnesyl pyrophosphate (FPP), which
derives from two precursors, isopentenyl pyrophosphate (IPP) and dimethylallyl
pyrophosphate (DMAPP). In general, there are two pathways for synthesising IPP
and DMAPP: the Mevalonate Pathway (starting with acetyl CoA) and the
Non-mevalonate Pathway (starting with pyruvate and glyceradehyde-3-phosphate).
While the Mevalonate Pathway is present in all higher eukaryotes, the Non-mevalonate Pathway is
present in E. coli.
Mevalonate Pathway (image adopted from Wikipedia, http://en.wikipedia.org/wiki/Mevalonate_pathway) |
Non-mevalonate Pathway (image adopted from Yuan et al.
2006) |
After IPP and DMAPP go
on to form FPP, a series of enzymatic reactions convert the colourless FPP to
coloured compounds: red lycopene, and orange β-carotene.
|
By modulating the enzymes
involved in this conversion pathway ("CrtE", "CrtB",
"CrtI", and "CrtY"), we aim to produce and control
different pigments as signal output.
DESIGN OF DEVICES
Biobricks contributed by previous iGEM teams
A few iGEM
teams of previous years (e.g.
Registry Code |
Team |
Sequence Description |
Size of insert |
K118014 |
|
922bp |
|
K118006 |
|
949bp |
|
K118005 |
|
1498bp 2 PstI sites removed. |
|
K118013 |
|
1162bp |
|
K152005 |
|
(rbs+CrtE) + (rbs+CrtB)
+ (rbs+CrtI) + (rbs+CrtY) + (rbs+GFP) |
5412bp 2 PstI sites in CrtI
removed. |
The above enzymes all come from a type of Gram negative
Enterobacteria, Pantoea ananatis (GenBank:
D90087.2). It is noted that analogues of these enzymes are also found in other
organisms (e.g. bacteria Rhodobacter
spp. and the fungus Neurospora crassa).
During our preliminary research, we have encountered a few
issues:
·
Originally, the registry annotation for K152005 indicated
that there was no ribosome binding site before gene CrtI (i.e.
“…rbs+CrtB+CrtI+rbs+CrtY…”). After clarification with Team Guelph 08, we were
told that it was an error in annotation. The registry entry for K152005 has
since been updated to include the ribosome binding site.
·
Teams of previous years constructed various composite parts
containing two or more enzymes of the synthetic pathways (e.g. CrtEBI,
CrtEBIY), but they are not available on the 2009 Distribution Plates.
·
We put K152005 under control of constitutive promoter
(R0011) and transformed the construct into E.coli TOP10 cells. However, the
plasmids seemed unstable (the colonies streaks on solid agar plates were
inconsistent in colour) and the pigment production was low. This indicated that
a different strain of E.coli might be needed for pigment production.
Create our own devices by standard assembly
Given the
information at hand, we decided to adopt the following general strategies:
- Create
a lycopene-producing device (with enzymes CrtE, CrtB and CrtI) by standard
assembly of Biobricks K118014, K118006 and K118005.
- Create
a β-carotene-producing device
(with enzymes CrtE, CrtB, CrtI and CrtY) by standard assembly of Biobricks
K118014, K118006, K118005 and K118013.
- Put the above two constructs under constitutive
promoter (R0011) and arabinose-induced promoter/Pbad (I0500) and test the
effect on colour production.
Scheme for standard assembly
|
Lycopene-producing
device |
β-carotene-producing
device |
Constituent
Biobricks (already in the registry) |
(K118014) (K118006) (K118005) |
(K118014) (K118006) (K118005) (K118013) |
Basic construct |
K274100 |
K274200 |
Under constitutive promoter |
K274110 |
K274210 |
Under Pbad promoter |
K274120 |
K274220 |
After constructing
our devices, we conducted restriction digest (cut with enzymes XbaI and PstI on
Biobrick prefix and suffix, respectively) to check that the sizes of the
inserts were correct. The results are as follows:
Biobrick Number |
Size of insert (kb) |
Size of backbone (kb) |
Note |
K274100 |
3.37 |
2.08 |
Digestion
result not shown. |
K274110 |
3.42 |
2.08 |
|
K274120 |
4.58 |
4.43 |
Sizes
of insert and backbone were similar so only one band appeared on gel. |
K274200 |
4.53 |
2.08 |
Digestion
result not shown. |
K274210 |
4.59 |
2.08 |
|
K274220 |
5.74 |
4.43 |
|
R0011-K152005* |
5.48 |
2.08 |
*These constructs were used in
preliminary research only. |
I0500-K152005* |
6.62 |
4.43 |
TESTING AND CHARACTERISATION
In vivo expression of
our devices in E.coli MG1655
Our preliminary research indicated that carotenoids
production in E.coli TOP10 was very weak. We decided to use another strain, E.coli MG1655, for in vivo expression of our devices. The amount of carotenoids
produced became visibly higher. Generally, the colour became visible after
incubation for about 12 hours.
Lycopene-producing device (constitutive)
|
|
E.coli MG1655 transformed with K274110
and grown on agar plate overnight. |
Cell pellet of E.coli MG1655
transformed with K274110 (from 20mL LB culture at |
β -carotene-producing device
(constitutive)
|
|
E.coli MG1655 transformed with K274210
and grown on agar plate overnight. |
Cell pellet of E.coli MG1655
transformed with K274210 (from 20mL LB culture at |
Quantitative measurement of pigment production
In
addition to visual inspection of coloured colonies, we hope to quantitatively
measure the amount of lycopene or β-carotene
produced by our devices. We grew transformed E.coli MG
Lycopene-producing device (constitutive)
Lycopene
in cells (pellet from 20mL LB culture at |
|
β -carotene-producing device
(constitutive)
β-carotene in cells (pellet from 20mL LB culture
at |
To investigate the
induction of pigment production, we tested our device K
β-carotene
in cells (pellet from 20mL LB culture at |
|
Discussion of results
Despite
relatively poor performance in E.coli
TOP10, our pigment-producing devices gave encouraging results in E.coli MG1655. Simply by overnight
incubation, the colonies were able to show visible colour changes. Since the
precursors were already present in normal E.coli,
no additional growth medium or special treatment was needed. This paves the way
to developing a signalling system that is quick to produce visual outputs.
The
acetone extraction of carotenoid provides a low-cost method for quantitative
measurement. In the above experiments, the results of photo-spectrometry were
consistent with characteristic absorbance wavelengths of lycopene (around
475nm) and β-carotene
(around 450nm), as noted in literature. In the case of β-carotene, the
absorbance profile of our β-carotene-producing device (K274210) matched
that of pure carotene standards, confirming that our device was functional in
the cells.
When we
overlay the graphs of our two devices (constitutive), we obtained the following
result:
|
red: K274110/lycopene; orange: K274210/β-carotene; black: pure β-carotene; blue: untransformed E.coli
MG1655 (negative control) |
Lycopene
and β-carotene showed characteristic absorbance profiles, with different
maximum absorbance wavelengths. It was tempted to think that by converting
lycopene to β-carotene (e.g. by expressing CrtY gene), we would be able to
see a “shift” in the peaks of maximum absorbance. However, in the bar charts
above it was noted that lycopene and β-carotene had significant absorbance
at both 456nm and 474nm, albeit with different ratios (i.e. lycopene absorbed
more at 474nm; β-carotene absorbed more at 456nm). Therefore, measurement
at a single wavelength was insufficient to determine the identity of the
carotenoid; we might need to use “456nm:474nm” ratio instead. It would be
interesting to see the effect of mixing different amounts of lycopene and β-carotene,
and whether the “456nm:474nm” ratio can indicate the relative percentage of
lycopene and β-carotene. In the current project, we were unable to obtain
pure lycopene due to high cost of purchase.
In terms
of inducing β-carotene production,
One
possible design using our devices is to construct a system where lycopene is
constitutively produced and CrtY, which converts red lycopene to orange β-carotene,
is controlled by external stimulus. Hence, the red cells will turn orange upon
sensing the specific external stimulus, and this change in colour serves as the
signal output that can be detected visually and measured quantitatively at low
cost.